Compare QNRX & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNRX | BTTC |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 13.4M |
| IPO Year | 2023 | N/A |
| Metric | QNRX | BTTC |
|---|---|---|
| Price | $4.90 | $1.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.1K | 20.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.80 | $1.07 |
| 52 Week High | $41.80 | $11.22 |
| Indicator | QNRX | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 29.59 | 31.27 |
| Support Level | N/A | N/A |
| Resistance Level | $6.84 | $1.41 |
| Average True Range (ATR) | 0.43 | 0.09 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 8.57 | 11.74 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.